Preparation H

Quick links to important sections

Preparation H

Selected form

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Preparation H

What is Preparation H? Overview

Property Description
Active Ingredients Phenylephrine hydrochloride, Mineral Oil, Petrolatum
Form Ointment, Cream, Suppository, Gel
Pharmacological Class Vasoconstrictor and Protectant
Common Use Temporary relief of hemorrhoidal symptoms
Origin Mixed-source (Synthetic chemical and pharmaceutical emollients)

What Type of Medicine is Preparation H?

Preparation H is classified as an Over-the-Counter (OTC) combination anorectal agent, a product line recognized for the symptomatic management of hemorrhoids. It is a combination drug product that uses several active ingredients to deliver a multi-action effect, intended for direct application to the affected area. This line of medicine is available in various dosage forms, including ointment, cream, suppository, and gel, which allows for both topical and rectal administration.

Composition and General Purpose of Preparation H

The formula's therapeutic action is derived from its two main component types: the synthetic Phenylephrine hydrochloride and the protectants such as Mineral Oil and Petrolatum. Phenylephrine belongs to the class of α1-adrenergic receptor agonists, which function as a vasoconstrictor. The inclusion of vasoconstrictors like phenylephrine is intended to reduce swelling by decreasing the size of local blood vessels. This mechanism is designed to ease discomfort by physically shrinking swollen hemorrhoidal tissue.

The general therapeutic purpose of the formulation is to address physical symptoms, providing temporary relief during episodes of acute flare-up. The vasoconstrictor component works to help temporarily shrink swollen tissue, while the protectants form a soothing, emollient barrier that shields irritated skin and membranes. This combined action is intended to relieve painful burning, itching, and discomfort associated with anorectal irritation.

What side effects are possible with Preparation H?

Possible Side Effects and Safety Information

The safety profile for Preparation H, which includes the vasoconstrictor Phenylephrine hydrochloride and the protectants Mineral Oil and Petrolatum, is classified according to official regulatory documentation. Adverse reactions are grouped by their potential frequency and the body system affected, focusing on both local application effects and the systemic potential of the active ingredients.


Official Adverse Reactions and Classifications

Adverse Reaction Type System-Organ Class Frequency Classification
Local Irritation (burning, stinging, discomfort) Skin and Subcutaneous Tissue Disorders Common
Allergic Reaction (e.g., rash, itching) Immune System / Skin Disorders Uncommon/Rare
Nervousness, Sleeplessness, Headache, Dizziness Nervous System / Psychiatric Disorders Uncommon/Rare
Increased Blood Pressure Cardiac Disorders Uncommon/Rare

Regulatory Safety Constraints

The most commonly classified side effects involve local irritation at the site of application. Reactions associated with the systemic absorption of the vasoconstrictor, such as increased blood pressure or nervousness, are officially documented but classified as less common.

Serious adverse reactions documented in the regulatory profile include the potential for severe systemic hypersensitivity (allergic reaction) and a significant systemic increase in blood pressure (hypertensive reaction), particularly when the product is used in excess or concurrently with certain other medications like Monoamine Oxidase Inhibitors (MAOIs).

Population and Duration Constraints: Official labeling includes high-level constraints for individuals with pre-existing conditions such as heart disease, high blood pressure, diabetes, or thyroid disease. Furthermore, use is generally limited to individuals 12 years of age and older. Regulatory safety standards require discontinuation if symptoms worsen or do not improve within 7 days.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information

This profile is based on authoritative government regulatory information concerning the potential for systemic toxicity from accidental exposure to the vasoconstrictor component, Phenylephrine hydrochloride.


Overdose Scope

Feature Official Regulatory Statement
Documented Manifestations Symptoms may include Hypertension (high blood pressure), Irregular heart rhythms, Reflex bradycardia (slowed heart rate), Severe headache, Nervousness, Nausea, and Vomiting.
Exposure-Related Factors The primary context for mandated emergency action is accidental oral ingestion (swallowing) of the product.
Population Considerations Children under 12 years of age are a specific population for whom use, and by extension, exposure, warrants prior consultation with a doctor.

Emergency Action Requirements

Feature Official Regulatory Statement
Immediate Medical Help Immediate action is required if the product is swallowed. The instruction is to get medical help or contact a Poison Control Center right away.
Severity Classification Overdose is classified as potentially leading to serious systemic effects, including hypertensive crisis and cardiac arrhythmias.

Resulting Overdose Structure

Official regulatory documents define the overdose profile by focusing on the critical safety trigger of accidental oral ingestion. This scenario mandates immediate action—contacting a Poison Control Center—due to the potential for the vasoconstrictor component to cause serious, documented systemic pressor manifestations such as high blood pressure and cardiac irregularities. Management focuses on symptomatic and supportive treatment to counteract these effects.

Therapeutic Uses of Preparation H

What Preparation H Treats: Main Uses and Benefits

The primary therapeutic domain of Preparation H products is relevant when supportive symptom management is appropriate for discomfort associated with conditions characterized by periods of heightened symptoms, specifically hemorrhoids and other minor anorectal disorders. Products in this category are intended for managing symptoms presenting with localized discomfort related to irritated anorectal tissue.

Preparation H is designed for easing core symptom clusters that can interfere with daily functioning, such as discomfort, itching, irritation, soreness, and burning. It is formulated for use during acute episodes and phases of increased distress. The use of these products during symptomatic phases is aimed at easing the overall symptom load.

“Contributes to easing the overall symptom load.”

This makes the product relevant when short-term symptomatic assistance is needed. The active ingredients are formulated to assist during episodes of heightened discomfort and to help maintain functional stability, which is often affected in conditions involving inflammatory or irritative processes.


Quick Fact: Relief for Symptoms that Interfere with Daily Functioning


Regulatory References

  1. Health Canada Anorectal Drug Products Labelling Standard

Eligibility and Restrictions for Use

Who Can and Cannot Use Preparation H?

Eligibility for over-the-counter (OTC) use of Preparation H is governed by specific patient criteria outlined in regulatory labeling. The product is generally intended for use by adults and children 12 years of age and older.

Contraindications and Restrictions

Contraindication (Do Not Use):

  • Individuals with a known hypersensitivity or allergy to any of the product's active ingredients (e.g., phenylephrine) or inactive components.

Mandatory Consultation (Ask a Doctor Before Use):

The following populations must consult a healthcare professional before using Preparation H due to potential risks or interactions:

Population/Condition Restriction Type
Children under 12 years old Age restriction
Heart disease or high blood pressure Cardiovascular risk
Thyroid disease or diabetes Endocrine/Metabolic risk
Enlarged prostate (difficulty urinating) Genitourinary risk
Taking prescription drugs for high blood pressure or depression Potential drug-drug interactions
Pregnant or breast-feeding Physiological state

Discontinue use and seek medical attention if bleeding occurs, if the condition worsens or does not improve within seven days, or if the applicator causes pain.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The regulatory interaction profile for Preparation H is defined by the systemic effects of its active vasoconstrictor component, Phenylephrine hydrochloride. The information presented is based strictly on authoritative government regulatory documentation.

The most severe documented interaction is classified as a formal contraindication due to the risk of inducing a hypertensive crisis, a severe elevation in blood pressure. Consequently, co-administration with Monoamine Oxidase Inhibitors (MAOIs) is strictly prohibited. This high-risk constraint necessitates a clear regulatory instruction: the product must not be used if a patient has taken an MAOI within the preceding 14-day period.

Documented Pharmacodynamic Interaction Outcomes

Interacting Substance Class Official Interaction Outcome
Monoamine Oxidase Inhibitors (MAOIs) Prohibited: Results in a highly potentiated pressor response.
Tricyclic Antidepressants, Corticosteroids Documented to increase the pressor effect of phenylephrine.
Alpha-1 Adrenergic Antagonists Documented to reduce the pressor effect of phenylephrine.

Other specific classes, including Nonselective Beta-Adrenergic Antagonists and Oxytocic Drugs, are also officially documented to potentiate the pressor action. Furthermore, regulatory sources explicitly state that there are no known interactions between this topical formulation and general foods or drinks. The overall interaction structure is defined by the absolute prohibition of MAOIs and the pressor-altering effects documented with these specific drug categories.

Mechanism of Action

Modulation of Vascular Tone via alpha1-Adrenergic Agonism

The ingredient Phenylephrine acts within the autonomic sympathetic pathway by functioning as a direct-acting agonist for the alpha1-adrenergic receptors (alpha1-AR) located on the walls of local blood vessels. This molecular interaction initiates a cascade that leads to the contraction of vascular smooth muscle (vasoconstriction). This peripheral action is a mechanism resulting in the altered vascular dynamics of engorged tissue, leading to a localized decrease in blood volume within the tissue.


Passive Physical Occlusion and Surface Shielding

The protectant components, Mineral Oil and Petrolatum, engage a non-pharmacological mechanism centered on passive physical occlusion. They establish a stable, hydrophobic barrier on the anorectal mucosal surface, which serves as a physical barrier against friction and external chemical contact. This physical mechanism results in surface hydration and physical isolation of the tissue by physically shielding sensitive sensory nerve endings from external irritants and reducing water loss (TEWL).

Dosage and Administration Information

Administration Routes and Standard Dosing

Preparation H is an over-the-counter anorectal agent administered via two distinct routes, depending on the specific dosage form. The product is used either topically/externally on the skin surrounding the anus or intrarectally in the lower anal canal, utilizing forms such as the ointment, cream, or suppository. All forms contain a fixed concentration of Phenylephrine hydrochloride 0.25%. The standard adult dosing regimen involves the application of a thin film or the insertion of one suppository, not to exceed a maximum of four times daily.


Frequency, Timing, and Duration

The dosing schedule is structured around functional events to ensure consistent administration. Standard application is typically timed in the morning, at night, and following each bowel movement. Use is intended for a short duration: the course of treatment is constrained by a 7-day time limit. If the condition worsens or shows no improvement within this 7-day period, discontinuation of the product is indicated.


Procedural and Population Rules

Proper administration requires certain procedural steps. When practical, the affected area is cleansed and gently dried immediately prior to application. For forms requiring internal use, the provided applicator is employed and subsequently thoroughly cleansed after each use. Furthermore, use rules address specific populations: administration of Preparation H to children under 12 years of age is restricted and requires consultation with a doctor.

Recent Clinical Evidence

Recent Clinical Evidence

The formulation marketed as Preparation H typically includes phenylephrine (a vasoconstrictor) or hydrocortisone (a corticosteroid), depending on the specific product. The clinical evidence surrounding these over-the-counter treatments generally focuses on their efficacy in temporarily relieving symptoms associated with hemorrhoids, such as itching, discomfort, and swelling.

Efficacy of Active Ingredients

Studies have investigated the roles of the primary active components in providing symptomatic relief:

  • Phenylephrine: As a vasoconstrictor, phenylephrine is studied for its ability to temporarily narrow blood vessels in the applied area, which may lead to a temporary reduction in swelling and discomfort. Evidence supports its use for the temporary relief of itching and minor pain associated with external hemorrhoids.
  • Hydrocortisone: As a mild corticosteroid, hydrocortisone is evaluated for its anti-inflammatory properties. Research examines whether it temporarily reduces inflammation and associated symptoms like chronic itching and pain, primarily in the external area.

Clinical Trial Findings

Clinical trials and systematic reviews generally support the use of these agents for short-term symptomatic relief of external hemorrhoidal symptoms. The research emphasizes that these products address symptoms only and are not treatments for the underlying cause of hemorrhoids.

Measurement Typical Study Finding
Symptom Onset Temporary relief of minor symptoms, often starting shortly after application.
Swelling Temporary reduction in localized swelling reported with vasoconstrictor use.
Itching/Pain Temporary relief, particularly with formulations containing an anti-inflammatory agent.

The evidence suggests that while these over-the-counter options may offer temporary comfort, effectiveness may vary among individuals. Their use is typically recommended for a limited duration, as prolonged use of certain components, such as topical corticosteroids, may be associated with side effects.

Frequently Asked Questions (FAQ)

Common questions about Preparation H (FAQ)

Q: What is the main difference between Preparation H cream and the suppositories?

According to the official product information, the primary difference is the route of administration. The ointment or cream can be applied topically (externally) and also intrarectally (internally) using an applicator. Suppositories, by contrast, are designed only for intrarectal insertion. Both product forms are indicated for temporarily relieving both internal and external hemorrhoidal discomfort.


Q: Are there any common over-the-counter medicines that shouldn't be taken with Preparation H?

The regulatory labeling advises consulting a healthcare professional when taking prescription drugs for high blood pressure or depression, due to potential interaction risks with the vasoconstrictor component. This consultation is generally recommended when considering use with other medications that contain similar systemic vasoconstricting ingredients.


Q: Does Preparation H work the same way for internal and external issues?

Yes, the official uses for the product indicate that it is intended to relieve both internal and external discomfort. The active vasoconstrictor component is described as temporarily shrinking swollen tissue regardless of whether it is applied externally or internally. The protectant ingredients, which form a physical barrier, also contribute to the soothing effect on the irritated tissue.


Q: Is Preparation H known to cause dryness or irritation over time?

Local irritation, such as burning or stinging, is a known and commonly reported side effect associated with the use of the product. Official labeling states that if irritation or other symptoms develop or increase during use, the product must be discontinued according to regulatory standards. The protectant components, however, are specifically included to help shield the tissue and prevent water loss.


Q: Are there different formulas of Preparation H for different needs?

Yes, different formulations are available that contain various active ingredients to target specific symptoms. Depending on the product, the active ingredients may include a vasoconstrictor like phenylephrine, a mild corticosteroid such as hydrocortisone, or a local anesthetic. These ingredients address different aspects of hemorrhoidal discomfort, such as swelling, itching, or pain.


Q: Is it possible to have an allergic reaction to one of the inactive ingredients in Preparation H?

Yes, official warnings advise that the product should not be used if a person has a known allergy or hypersensitivity to any of the ingredients. This restriction applies equally to the active pharmaceutical ingredients and the inactive components, such as preservatives or emollients, found in the specific formulation.


Q: Why might a person not see the expected results from using Preparation H?

Official instructions indicate that if the condition worsens or shows no improvement within seven days, the product should be discontinued and a healthcare professional consulted, as required by regulatory standards. This guidance suggests that the product may not be appropriate or effective for all causes or stages of discomfort, and persistence of symptoms may require diagnosis.


Q: Does Preparation H contain any steroids or similar compounds?

Some products within the Preparation H line contain the active ingredient hydrocortisone, which is classified as a mild corticosteroid. Other formulations rely on ingredients like phenylephrine (a vasoconstrictor) and protectants. It is important to check the Drug Facts label of the specific product to confirm its active ingredients.


Q: Can I use Preparation H if I have sensitive skin or other skin conditions?

The product is explicitly for anorectal use only. Regulatory documents warn that the product should not be used on broken skin, large sores, cuts, scrapes, or burns in the area of application. Individuals with pre-existing skin conditions or sensitive skin should note that local irritation is a commonly reported side effect.


Q: Are there any long-term safety concerns described in official documents regarding Preparation H?

Regulatory labeling restricts the product's use to a maximum of seven days. Official labeling requires the product to be discontinued if symptoms persist or worsen after this period. This time restriction acts as a safety control, as prolonged use may be associated with side effects or could mask a more serious underlying medical condition that requires diagnosis.


Q: What are the official sources for information about Preparation H's safety?

The safety and usage information is derived from authoritative government drug agencies and public databases. These sources include the U.S. Food and Drug Administration (FDA) DailyMed database, the National Institutes of Health (NIH) MedlinePlus, and the labeling documentation provided by national regulatory agencies in various regions.


Q: Can Preparation H be used alongside prescribed topical treatments?

The regulatory labeling advises consulting a healthcare professional before use if a person is taking certain prescription drugs, such as those for high blood pressure or depression. While specific guidance on combining it with other prescribed topical treatments is not explicitly provided, a consultation with a healthcare professional is noted in regulatory documents as important for drug combinations to understand potential interactions.


Q: Is Preparation H available by prescription only in some regions?

In the United States and Canada, Preparation H is generally regulated as an Over-the-Counter (OTC) drug, meaning a prescription is not required for purchase. Its classification is defined by the governing drug authority in each region. The status of the product may differ depending on the local regulatory body.


Q: What happens if I forget to apply Preparation H at my usual time?

Regulatory information for similar topical anorectal products containing phenylephrine generally indicates that if a scheduled application is missed, it is applied as soon as the user remembers. Following this, the user typically returns to their regular application schedule.


Q: What should be done if I accidentally swallow a small amount of Preparation H?

Official warnings on the product label instruct that if the product is swallowed, medical help must be sought immediately. This may involve contacting a medical professional or calling a certified Poison Control Center.


Q: Are the safety profiles different for the various forms of Preparation H (wipes, creams, etc.)?

Regulatory documentation typically lists adverse reactions based on the active ingredients, such as phenylephrine or hydrocortisone, and these systemic effects are generally independent of the physical form of the product. However, different forms contain different inactive ingredients, which could slightly alter the risk of local irritation or allergic reaction.


Q: What is the purpose of the cooling or soothing components in some Preparation H products?

Some formulations are described in official documents as containing additional soothing components to enhance temporary relief from pain and itching. These ingredients may include local anesthetics like pramoxine or astringents such as witch hazel. They work to provide relief beyond the vasoconstrictor effect.


Q: What information is available regarding the safety of using Preparation H near other body areas?

Official product warnings explicitly limit the use of Preparation H to the anorectal area (external or intrarectal) only. Furthermore, the label advises users to avoid contact with the eyes. The regulatory label indicates that the product is intended only for the area of the body for which it is labeled.


Q: Do official sources discuss the possibility of tolerance to Preparation H over time?

Regulatory standards establish a strict limit of seven days for product use. This duration constraint is a control measure intended to prevent potential issues that might arise from long-term use, such as a lack of response. It also ensures that a persistent medical issue is not masked.

How should Preparation H be stored and disposed of?

How to Store and Dispose of Preparation H?

The proper storage and disposal of Preparation H are defined by regulatory guidelines to ensure product stability and safety. This product must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F). It is essential to keep the product from freezing and to avoid excessive heat above the required range to maintain product integrity.

Key Storage and Disposal Requirements

Category Regulatory Requirement
Temperature Store at 20 C to 25 C.
Handling Keep from freezing; avoid excessive heat.
Child Safety Keep out of reach of children.
Disposal Do not flush; dispose of unused medicine via a drug take-back program or secure household trash.

Users must not use the medicine after the expiration date printed on the carton. For disposal, official guidance requires avoiding wastewater systems and recommends utilizing a drug take-back program or following local non-hazardous waste instructions.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Preparation H found in:

A-Z Index: